IGM Biosciences

IGM Biosciences is pioneering a new class of antibody drugs for the treatment of cancer, infectious diseases, as well as autoimmune and inflammatory conditions. Leveraging the enhanced binding capabilities provided by the structure of naturally occurring IgM antibodies, compared to commonly used IgG antibody structures, IGM has been able to create "super antibodies," which have the potential to offer patients new therapeutic options and hope.